The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
“States are in the best position to enter into global settlements and to protect all communities through statewide implementation of policy and ensuring equitable distribution of available funds,” one brief stated.
Home » PHARMACEUTICAL SPEND ON OUTSOURCING FACES DOUBLE-DIGIT GROWTH FOR THE NEXT THREE TO FIVE YEARS
FDAnews Drug Daily Bulletin
PHARMACEUTICAL SPEND ON OUTSOURCING FACES DOUBLE-DIGIT GROWTH FOR THE NEXT THREE TO FIVE YEARS
Research and Markets has announced the addition of Outsourcing Clinical Development
to their offering. The challenges facing large pharmaceutical companies are stark:
sales are slowing, and research and development costs are rising. There is an
overwhelming need to reduce development costs by as much as 30-40%, while at the
same time significantly shortening development cycle times.